Adoptive immunotherapy with enhanced T lymphocyte survival

Details for Australian Patent Application No. 2005336093 (hide)

Owner Government of the United States of America, Represented by The Secretary, Department of Health and Human Services

Inventors Rosenberg, Steven A.; Hsu, Cary; Morgan, Richard A.

Agent Fisher Adams Kelly

Pub. Number AU-B-2005336093

PCT Pub. Number WO2007/037780

Priority 60/617,340 08.10.04 US; 60/617,768 12.10.04 US

Filing date 7 October 2005

Wipo publication date 3 May 2007

Acceptance publication date 24 February 2011

International Classifications

C12N 5/0783 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

Event Publications

3 May 2007 Application Open to Public Inspection

  Published as AU-B-2005336093

3 May 2007 PCT application entered the National Phase

  PCT publication WO2007/037780 Priority application(s): WO2007/037780

18 December 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Corrigenda Name Government of the United States of America, Represented by The Secretary, Department of Health and Human Services, Application No. 2005336093, under INID (43) correct the date to 5 April 2007

24 February 2011 Application Accepted

  Published as AU-B-2005336093

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005336100-Biocompatible polymeric compositions for use in making anterior chamber intraocular lenses

2005336092-Methods for diagnosis and treatment of cancer